Management of Patients With Recovered Systolic Function

Progress in Cardiovascular Diseases
Anupam Basuray, James C Fang

Abstract

Advancements in the treatment of heart failure (HF) with systolic dysfunction have given rise to a new population of patients with improved ejection fraction (EF). The management of this distinct population is not well described due to a lack of consensus on the definition of myocardial recovery, a scarcity of data on the natural history of these patients, and the absence of focused clinical trials. Moreover, an improvement in EF may have different prognostic and management implications depending on the underlying etiology of cardiomyopathy. This can be challenging for the clinician who is approached by a patient inquiring about a reduction of medical therapy after apparent EF recovery. This review explores management strategies for HF patients with recovered EF in a disease-specific format.

References

Sep 1, 1990·Journal of the American College of Cardiology·F E CruzH J Wellens
Jul 1, 1986·Journal of the American College of Cardiology·J B O'ConnellR M Gunnar
Aug 1, 1986·Journal of the American College of Cardiology·P S RahkoB F Uretsky
Jan 1, 1987·American Heart Journal·J RiversA Murphy
Mar 1, 1986·The American Journal of Cardiology·D L PackerL D German
Jan 18, 1985·JAMA : the Journal of the American Medical Association·P C GilletteD G McNamara
Mar 1, 1985·British Heart Journal·C J McLaranD R Holmes
Dec 1, 1971·Circulation·J G DemakisR M Gunnar
Aug 1, 1994·Journal of the American College of Cardiology·M J SemigranG W Dec
Mar 1, 1993·American Heart Journal·M TeragakiT Takeda
Jan 1, 1997·American Journal of Obstetrics and Gynecology·M B LampertR M Lang
Apr 1, 1997·Pacing and Clinical Electrophysiology : PACE·J A ChiladakisA S Manolis
Feb 2, 2000·European Heart Journal·L FauchierJ P Fauchier
Mar 9, 2000·The New England Journal of Medicine·R E McCarthyK L Baughman
Apr 27, 2000·The American Journal of Cardiology·A GavazziM Porcu
May 24, 2001·The New England Journal of Medicine·U ElkayamA Shotan
Feb 6, 2002·Annals of Internal Medicine·Josep María NicolásEmanuel Rubin
Oct 23, 2002·Circulation·Milton PackerUNKNOWN Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group
Apr 2, 2003·The New England Journal of Medicine·Bertram PittUNKNOWN Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators
Jan 27, 2005·JAMA : the Journal of the American Medical Association·Timothy M OlsonJeffrey L Anderson
Apr 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S Ewer, Scott M Lippman
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S EwerDaniel J Lenihan
Aug 23, 2006·American Heart Journal·Ankie M AmosStuart D Russell
Oct 13, 2006·The New England Journal of Medicine·Kevin C OeffingerUNKNOWN Childhood Cancer Survivor Study
Nov 3, 2006·The New England Journal of Medicine·Emma J BirksMagdi H Yacoub
Jul 31, 2007·Journal of the American College of Cardiology·Ahmad A ElesberCharanjit S Rihal
Mar 19, 2008·Heart·Steven E LipshultzRebecca E Scully

❮ Previous
Next ❯

Citations

Nov 23, 2016·Expert Review of Medical Devices·Karolina K MarinescuDaniel Burkhoff
Apr 8, 2017·European Journal of Heart Failure·Josep LupónAntoni Bayés-Genís
Apr 5, 2018·Current Treatment Options in Cardiovascular Medicine·Peter Unkovic, Anupam Basuray
Sep 16, 2018·Journal of Echocardiography·Kazuaki Tanabe, Takahiro Sakamoto
Sep 22, 2017·Nature Reviews. Cardiology·Gene H KimDaniel Burkhoff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology
Sarinya PuwanantKrishnaswamy Chandrasekaran
© 2022 Meta ULC. All rights reserved